Protective Effects of Vitamin C against Neomycin-Induced Apoptosis in HEI-OC1 Auditory Cell

Liang Gong1, Biao Chen1, Jingyuan Chen1

  • 1Department of Otorhinolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing 100005, China.

Neural Plasticity
|May 23, 2022
PubMed

Insights

Vitamin C (VC) protects against neomycin-induced ototoxicity by reducing reactive oxygen species (ROS) and inhibiting apoptosis in hair cells. This suggests VC as a potential therapeutic agent for preventing hearing loss.

Area of Science:

  • Oto-toxicology
  • Cell Biology
  • Biochemistry

Background:

  • Ototoxic hearing loss stems from hair cell death driven by excessive reactive oxygen species (ROS) and apoptosis.
  • Neomycin is a common ototoxic agent that induces hair cell damage.

Purpose of the Study:

  • To investigate the protective effects of vitamin C (VC) against neomycin-induced damage in HEI-OC1 cells.
  • To elucidate the underlying inhibitory mechanisms of VC.

Main Methods:

  • HEI-OC1 cells were exposed to neomycin and/or vitamin C.
  • Assessed cell viability, ROS generation, apoptosis markers (Bcl-2, Bax, caspase-3, caspase-8), and signaling pathways (JNK, p38).
  • TUNEL labeling was used to confirm apoptosis inhibition.

Main Results:

  • Vitamin C demonstrated a protective effect against neomycin-induced HEI-OC1 cell death.
  • VC significantly decreased ROS generation, suppressed apoptosis, and enhanced cell viability.
  • VC modulated apoptotic markers, inhibiting proapoptotic proteins and restoring antiapoptotic expression, while also interfering with JNK and p38 activation.

Conclusions:

  • Vitamin C mitigates neomycin-induced ototoxicity by suppressing ROS production and counteracting apoptotic signaling pathways.
  • VC shows potential as a protective agent against neomycin-induced hair cell damage and subsequent ototoxicity.